Updates on Current Therapies for Esophagus and Esophageal Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 673
Special Issue Editors
Interests: esophageal cancer; gastric cancer; surgical oncology
Interests: esophageal cancer; gastric cancer; surgical oncology
Interests: esophageal cancer; gastric cancer; surgical oncology
Special Issue Information
Dear Colleagues,
Characterized by its aggressive nature, high morbidity and mortality rates, esophageal cancer represents a global health burden. Aiming to enhance early detection, refine diagnostic approaches, and develop more effective treatment strategies, extensive research efforts have been dedicated to unraveling the intricate complexities of this disease.
As a result, personalized treatment with targeted therapies, immunotherapies, and combination treatment regimens have emerged as promising avenues for combating esophageal cancer while minimizing adverse effects.
While surgical intervention remains a mainstay in the management of esophageal cancer, researchers have been actively exploring minimally invasive and organ-preserving approaches to reduce invasiveness, encourage faster recovery, and improve quality of life for patients.
The challenges posed by advanced and metastatic esophageal cancer necessitate a concerted effort to develop more effective systemic therapies.
Addressing the holistic needs of patients with cancer is a matter of paramount importance. The management of treatment-related side-effects, nutritional support, psychosocial care, and survivorship issues are essential components of comprehensive patient care.
Research submitted to this Issue should aim to enhance patient well-being, optimize treatment adherence, and foster improved quality of life throughout the cancer journey.
We extend our deepest gratitude to the authors for their exceptional contributions and hope that this Special Issue will serve as a catalyst for further progress in the treatment of esophageal cancer.
Dr. Elisa Sefora Pierobon
Dr. Lucia Moletta
Dr. Giovanni Capovilla
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- esophageal cancer
- adenocarcinoma
- squamous cell carcinoma
- molecular profiling
- personalized treatment
- surgical innovation
- supportive care
- quality of life
- survivorship
